Cargando…
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals
INTRODUCTION: Thallium-201 is a radionuclide that has previously been used clinically for myocardial perfusion scintigraphy. Although in this role it has now been largely replaced by technetium-99 m radiopharmaceuticals, thallium-201 remains attractive in the context of molecular radionuclide therap...
Autores principales: | Rigby, Alex, Blower, Julia E., Blower, Philip J., Terry, Samantha Y.A., Abbate, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610824/ https://www.ncbi.nlm.nih.gov/pubmed/33906122 http://dx.doi.org/10.1016/j.nucmedbio.2021.03.012 |
Ejemplares similares
-
In vitro proof of concept studies of radiotoxicity from Auger electron-emitter thallium-201
por: Osytek, Katarzyna M., et al.
Publicado: (2021) -
Toward Bifunctional Chelators for Thallium-201 for
Use in Nuclear Medicine
por: Rigby, Alex, et al.
Publicado: (2022) -
In vitro cytotoxicity of Auger electron-emitting [(67)Ga]Ga-trastuzumab
por: Othman, Muhamad Faiz bin, et al.
Publicado: (2020) -
The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
por: Kleynhans, Janke, et al.
Publicado: (2022) -
Influence of Storage Temperature on Radiochemical Purity of (99m)Tc-Radiopharmaceuticals
por: Uccelli, Licia, et al.
Publicado: (2018)